Mesenchymal stromal cell-based therapy in kidney diseases and transplantation

by Federica Casiraghi, Giuseppe Remuzzi
Published 2019-03-01

Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?

by Sistiana Aiello, Federica Casiraghi
Published 2021-06-01

Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation

by Manuel Alfredo Podestà, Giuseppe Remuzzi, Federica Casiraghi
Published 2021-02-01

Mesenchymal Stromal Cells for Transplant Tolerance

by Manuel Alfredo Podestà, Manuel Alfredo Podestà, Giuseppe Remuzzi, Federica Casiraghi
Published 2019-06-01

Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice

by Federica Casiraghi, Pamela Yossenaidy Rodriguez Ordonez, Nadia Azzollini, Marta Todeschini, Daniela Rottoli, Roberta Donadelli, Roberto Gramignoli, Ariela Benigni, Marina Noris, Giuseppe Remuzzi
Published 2021-06-01

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration

by Federica Casiraghi, Norberto Perico, Eliana Gotti, Marta Todeschini, Marilena Mister, Monica Cortinovis, Valentina Portalupi, Anna Rita Plati, Flavio Gaspari, Alessandro Villa, Martino Introna, Elena Longhi, Giuseppe Remuzzi
Published 2020-04-01

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy

by Norberto Perico, Federica Casiraghi, Marta Todeschini, Monica Cortinovis, Eliana Gotti, Valentina Portalupi, Marilena Mister, Flavio Gaspari, Alessandro Villa, Sonia Fiori, Martino Introna, Elena Longhi, Giuseppe Remuzzi, Giuseppe Remuzzi, Giuseppe Remuzzi
Published 2018-06-01